Literature DB >> 6986413

In vitro idiotypic suppression of chronic lymphocytic leukemia lymphocytes secreting monoclonal immunoglobulin M anti-sheep erythrocyte antibody.

C A Bona, A S Fauci.   

Abstract

A patient with chronic lymphocytic leukemia was found to have B cells with surface immunoglobulin (Ig)M manifesting anti-sheep erythrocyte (SRBC) specificity together with a high titer serum monoclonal anti-SRBC IgM antibody. By immunizing a sheep with the monoclonal IgM antibody, followed by multiple absorptions against normal human IgM, an anti-idiotype (Id) antibody was obtained. The serum IgM anti-SRBC antibody was then demonstrated to share the same idiotypic determinants with the surface IgM with anti-SRBC specificity on the patient's B cells. The anti-Id antibody suppressed the spontaneous secretion of anti-SRBC antibody as well as the pokeweed mitogen-induced anti-SRBC antibody production as measured by a hemolysis-in-gel plaque-forming cell assay. In contrast, pokeweed mitogen-induced anti-SRBC plaque-forming cell responses of normal individuals were not suppressed by the anti-Id antibody. Thus, this study demonstrates in vitro suppression of human B-cell function by anti-Id antibody.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6986413      PMCID: PMC371420          DOI: 10.1172/JCI109724

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes.

Authors:  S M Fu; R J Winchester; T Feizi; P D Walzer; H G Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

2.  Polyclonal activation of bone-marrow-derived lymphocytes from human peripheral blood measured by a direct plaque-forming cell assay.

Authors:  A S Fauci; K R Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

Review 3.  Studies of structure and immunosuppression of cross-reactive idiotype in strain A mice.

Authors:  A Nisonoff; S T Ju; F L Owen
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

4.  Idiotype suppression. II. Amplification of a suppressor T cell with anti-idiotypic activity.

Authors:  K Eichmann
Journal:  Eur J Immunol       Date:  1975-08       Impact factor: 5.532

Review 5.  B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.

Authors:  M Seligmann; J L Preud'Homme; J C Brouet
Journal:  Transplant Rev       Date:  1973

6.  Myeloma proteins as tumor-specific transplantation antigens.

Authors:  R G Lynch; R J Graff; S Sirisinha; E S Simms; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

7.  Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals.

Authors:  A S Fauci
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

8.  Regulation of immune response by autogenous antibody against receptor.

Authors:  L Kluskens; H Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

9.  Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes.

Authors:  A S Fauci; K R Pratt
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

10.  Occurrence of surface IgM, IgD, and free light chains of human lymphocytes.

Authors:  S M Fu; R J Winchester; H G Kunkel
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Cellular localization of rheumatoid factor idiotypes.

Authors:  V R Bonagura; H G Kunkel; B Pernis
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

3.  Spontaneous in vitro differentiation of antigen-specific lymphocytes from a patient with immunoglobulin M gammopathy.

Authors:  J Halper; E A Kabat; E F Osserman; P Tonda; B Pernis
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

4.  Suppression of in vitro monoclonal human rheumatoid factor synthesis by antiidiotypic antibody. Target cells and molecular requirements.

Authors:  W J Koopman; R E Schrohenloher; J C Barton; E C Greenleaf
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  Regulation of immunoglobulin E antibody synthesis in man by antiidiotypic antibodies.

Authors:  R S Geha; M Comunale
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

6.  Paraproteinaemia: use of idiotypic determinants as specific markers for tumour activity.

Authors:  M A King; J Vivianwells
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

7.  Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: a guide for immunotherapy.

Authors:  F K Stevenson; M J Glennie; D M Johnston; A L Tutt; G T Stevenson
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.